Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: colon cancer + cancer + chemotherapy  Related to the article below (Last Update: 8/5/2008)

YM BIOSCIENCES REPORTS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC ...
FOXBusiness -
"The results support further development of nimotuzumab in this setting and trials in metastatic colorectal cancer are high on the list of indications that ...YMI - OTC:CMTX
Turned-off cannabinoid receptor turns on colorectal tumor growth
Hindu, India - Aug 3, 2008
HOUSTON - New preclinical research shows that cannabinoid cell surface receptor CB1 plays a tumor-suppressing role in human colorectal cancer, ...
/REPEAT -- Diagnocure announces the formation of a new Strategic ...
Canada NewsWire (press release), Canada -
"The Previstage(TM) GCC test may improve upon the staging of colorectal cancer that is the major basis for the decision on whether or not chemotherapy is ...TSE:CUR - GPRO
Teacher Learns The ABC?s Of Balancing Cancer And Career
North American Press Syndicate, NY -
Note To The Editor: Xeloda is the only FDA-approved oral chemotherapy for both metastatic breast cancer and adjuvant and metastatic colorectal cancer. ...
Cannabis-Linked Cell Receptor Might Help Prevent Colon Cancer
Washington Post, United States - Aug 1, 2008
1 (HealthDay News) -- A cannabinoid receptor lying on the surface of cells may help suppress colorectal cancer, say US researchers. ...
Radiofrequency Ablation Effective for Primary Lung Tumors and Lung ...
Cancer Consultants, ID -
The use of radiofrequency ablation for the treatment of lung cancer and lung metastases from breast, colon, and prostate cancers and melanoma is effective ...
Terminal cancer patients not given chemo info
Reuters - Aug 1, 2008
NEW YORK (Reuters Health) - Patients with incurable cancer are often not clearly informed of what they stand to gain from palliative chemotherapy, ...
Cancer Patients Are Not Given Enough Information, Experts Say
Science Daily (press release) - Jul 31, 2008
ScienceDaily (July 31, 2008) ? Two thirds of cancer patients receive little or no information about the survival benefits of having palliative chemotherapy ...
Study links vitamin D to colon cancer survival
Australia.TO, Australia - Aug 2, 2008
Ng said that a trial is being planned in which colon cancer patients will take vitamin D along with post-surgery chemotherapy to look for any benefits of ...
Patients With Colon Cancer Who Have A Family History Of Colorectal ...
Medical News Today (press release), UK - Jul 30, 2008
The study followed up 1087 patients with stage III colon cancer - cancer that has spread from the colon to the lymph glands but not to other parts of the ...
Source: Google News

Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in … -
W Scheithauer, H Rosen, GV Kornek, C Sebesta, D … - BMJ: British Medical Journal, 1993 - pubmedcentral.nih.gov
... CONCLUSIONS--In this sample of patients with disseminated colorectal cancer the
chemotherapy regimen was an effective form of palliative treatment. ...

… Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer -
CM Ribic, DJ Sargent, MJ Moore, SN Thibodeau, AJ … - New England Journal of Medicine, 2003 - content.nejm.org
... Next Next. Tumor Microsatellite-Instability Status as a Predictor of Benefit
from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer. ...

Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer -
T Watanabe, TT Wu, PJ Catalano, T Ueki, R Satriano … - New England Journal of Medicine, 2001 - content.nejm.org
... Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability..
Clin. ... Molecular Predictors of Survival After Colon Cancer Chemotherapy. ...

Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant Chemotherapy. -
H Bismuth, R Adam, F L?vi, C Farabos, F Waechter, … - Annals of Surgery, 1996 - annalsofsurgery.com
... Resection of Nonresectable Liver Metastases from Colorectal Cancer After
Neoadjuvant Chemotherapy. ... Chemotherapy for colorectal cancer. ...

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer -
H Hurwitz, L Fehrenbacher, W Novotny, T Cartwright … - The New England Journal of Medicine, 2004 - nejm.org
... An open-label, single-arm study assessing safety and efficacy of panitumumab in
patients with metastatic colorectal cancer refractory to standard chemotherapy. ...
-

… of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy … -
S Giacchetti, M Itzhaki, G Gruia, R Adam, R Zidani … - Annals of Oncology, 1999 - Springer
... Long-term survival of patients with unresectable colorectal cancer liver metastases
following infusional chemotherapy with 5-?uorouracil, leucovorin ...

… Arterial Infusion of Chemotherapy after Resection of Hepatic Metastases from Colorectal Cancer -
N Kemeny, Y Huang, AM Cohen, W Shi, JA Conti, MF … - New England Journal of Medicine, 1999 - content.nejm.org
... Occlusion of the Left Superficial Femoral Artery During Hepatic Arterial Infusion
of Chemotherapy for Liver Metastases from Colon Cancer 18 Months After the ...

… cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy -
P Rougier, R Bugat, JY Douillard, S Culine, E Suc, … - Journal of Clinical Oncology, 1997 - jco.ascopubs.org
... Phase II study of irinotecan in the treatment of advanced colorectal cancer in
chemotherapy-naive patients and patients pretreated with fluorouracil-based ...

A Pooled Analysis of Adjuvant Chemotherapy for Resected Colon Cancer in Elderly Patients -
DJ Sargent, RM Goldberg, SD Jacobson, JS Macdonald … - New England Journal of Medicine, 2001 - content.nejm.org
... Duration of Adjuvant Chemotherapy for Colon Cancer and Survival Among the Elderly. ...
Adjuvant Chemotherapy for Resected Colon Cancer in the Elderly. ...

Chemotherapy for Colorectal Cancer -
CG Moertel - New England Journal of Medicine, 1994 - content.nejm.org
... Next Next. Chemotherapy for Colorectal Cancer. Charles G. Moertel. ... Chemotherapy
for Colorectal Cancer. NEJM 331: 680-681 [Full Text]. ...

Source: Google Scholar
 
 

Pre-surgery chemo ups colon cancer survival

 
 

In patients with advanced colorectal cancer that has spread to the liver, the tumors may initially be impossible to remove adequately by surgery. In this situation, prior chemotherapy improves surgical outcomes, according to a new report.

This approach "increases the overall survival rate but not the disease-free survival rate," Dr. L. Capussotti told Reuters Health.

Capussotti from Istituto per la Ricerca e la Cura del Cancro, in Candiolo, Italy, and colleagues reviewed the outcomes for 150 patients who underwent surgery for colorectal tumors that had spread to the liver; 34 of the patients had chemotherapy before liver surgery, because their tumors were more advanced.

No patient died in-hospital after their liver resection, the investigators report in the British Journal of Surgery, and the overall rate of postoperative complications did not differ significantly between patients who had preoperative chemotherapy and those who did not.

Overall survival at 1 and 3 years was 95.3 percent and 62.8 percent, respectively, and did not differ significantly between the groups, the researchers note.

These survival rates were better than those experienced by patients who did not have liver surgery after chemotherapy -- 83.2 percent and 21.3 percent at 1 and 3 years, respectively.

Recurrence rates were high, the report indicates, and occurred in nearly three quarters of the patients who had surgery without chemotherapy and 94 percent of those who had chemotherapy before liver resection.

"Based on these data, it is clear that the combination of (pre-surgery) chemotherapy and liver resection greatly increases survival compared with chemotherapy alone, but rarely provides cure," the team concludes.

"Surgeons and oncologists should work together to increase the disease-free survival rate," Dr. Capussotti said, perhaps through "better selection of the patients for surgery (or) more aggressive chemotherapy."

SOURCE: British Journal of Surgery, August 2006.

Copyright © 2006 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

 
 
 
Google
Web www.iconocast.com
 
 
 

 

Continue News With: News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services. Home

 © 2002-2006

Keywords::

Contact Iconocast

Home Page